Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether a geriatric assessment can lead to better treatment outcomes
in older patients (age 60+) with a myeloid malignancy including acute myeloid leukemia,
,myelodysplastic syndromes, myeloproliferative neoplasms, or related blood disorders who are
going to receive chemotherapy or another treatment to prepare the body for an allogeneic
hematopoietic stem cell transplant (allo-HCT). The geriatric assessment includes looking at
patients' cognitive function (thinking processes), physical function, mobility (ability to
move the body), mood, nutrition, and current medications to help decide the type of treatment
they'll receive.
Another purpose of this study is to see whether use of the geriatric assessment improves
participants' quality of life. We will evaluate participants' quality of life through
questionnaires.